133 related articles for article (PubMed ID: 26802625)
21. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Palazuelos J; Aguado T; Pazos MR; Julien B; Carrasco C; Resel E; Sagredo O; Benito C; Romero J; Azcoitia I; Fernández-Ruiz J; Guzmán M; Galve-Roperh I
Brain; 2009 Nov; 132(Pt 11):3152-64. PubMed ID: 19805493
[TBL] [Abstract][Full Text] [Related]
22. A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir.
Merz SF; Bengtson CP; Tepohl C; Hagenston AM; Bading H; Bas-Orth C
Mol Brain; 2020 Sep; 13(1):124. PubMed ID: 32928261
[TBL] [Abstract][Full Text] [Related]
23. Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus.
Imamura Y; Ma CL; Pabba M; Bergeron R
J Neurochem; 2008 Jun; 105(6):2454-65. PubMed ID: 18331477
[TBL] [Abstract][Full Text] [Related]
24. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
[TBL] [Abstract][Full Text] [Related]
25. PnAn13, an antinociceptive synthetic peptide inspired in the
Emerich BL; Ferreira RCM; Machado-de-Avila RA; Resende JM; Duarte IDG; de Lima ME
Toxicon X; 2020 Sep; 7():100045. PubMed ID: 32875290
[TBL] [Abstract][Full Text] [Related]
26. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
[TBL] [Abstract][Full Text] [Related]
27. Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors.
Rönicke R; Mikhaylova M; Rönicke S; Meinhardt J; Schröder UH; Fändrich M; Reiser G; Kreutz MR; Reymann KG
Neurobiol Aging; 2011 Dec; 32(12):2219-28. PubMed ID: 20133015
[TBL] [Abstract][Full Text] [Related]
28. Calpain regulation of AMPA receptor channels in cortical pyramidal neurons.
Yuen EY; Gu Z; Yan Z
J Physiol; 2007 Apr; 580(Pt 1):241-54. PubMed ID: 17234699
[TBL] [Abstract][Full Text] [Related]
29. Involvement of P38MAPK activation by NMDA receptors and non-NMDA receptors in amyloid-β peptide-induced neuronal loss in rat hippocampal CA1 and CA3 subfields.
Xu Y; Cao DH; Wu GM; Hou XY
Neurosci Res; 2014 Aug; 85():51-7. PubMed ID: 24929103
[TBL] [Abstract][Full Text] [Related]
30. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
31. Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical cells.
Lee BY; Ban JY; Seong YH
Neurosci Res; 2005 Aug; 52(4):347-56. PubMed ID: 15896866
[TBL] [Abstract][Full Text] [Related]
32. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
Chen Q; Surmeier DJ; Reiner A
Exp Neurol; 1999 Sep; 159(1):283-96. PubMed ID: 10486197
[TBL] [Abstract][Full Text] [Related]
33. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model.
Jarabek BR; Yasuda RP; Wolfe BB
Brain; 2004 Mar; 127(Pt 3):505-16. PubMed ID: 14662521
[TBL] [Abstract][Full Text] [Related]
34. Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease.
Calabresi P; Centonze D; Pisani A; Bernardi G
Exp Neurol; 1999 Jul; 158(1):97-108. PubMed ID: 10448421
[TBL] [Abstract][Full Text] [Related]
35. An Improved Drugs Screening System Reveals that Baicalein Ameliorates the Aβ/AMPA/NMDA-Induced Depolarization of Neurons.
Lin TS; Tsai HJ; Lee CH; Song YQ; Huang RS; Hsieh-Li HM; Liang MC; Lin Y
J Alzheimers Dis; 2017; 56(3):959-976. PubMed ID: 28106556
[TBL] [Abstract][Full Text] [Related]
36. PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors.
Gerace E; Masi A; Resta F; Felici R; Landucci E; Mello T; Pellegrini-Giampietro DE; Mannaioni G; Moroni F
Neurobiol Dis; 2014 Oct; 70():43-52. PubMed ID: 24954469
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus.
Kim JH; Cho SY; Lee JH; Jeong SM; Yoon IS; Lee BH; Lee JH; Pyo MK; Lee SM; Chung JM; Kim S; Rhim H; Oh JW; Nah SY
Brain Res; 2007 Mar; 1136(1):190-9. PubMed ID: 17239831
[TBL] [Abstract][Full Text] [Related]
38. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
Louzada PR; Paula Lima AC; Mendonca-Silva DL; Noël F; De Mello FG; Ferreira ST
FASEB J; 2004 Mar; 18(3):511-8. PubMed ID: 15003996
[TBL] [Abstract][Full Text] [Related]
39. PhTx3-4, a Spider Toxin Calcium Channel Blocker, Reduces NMDA-Induced Injury of the Retina.
Binda NS; Carayon CP; Agostini RM; Pinheiro AC; Cordeiro MN; Silva MA; Silva JF; Pereira EM; da Silva Junior CA; de Castro Junior CJ; Guimarães AL; Gomez MV
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26978403
[TBL] [Abstract][Full Text] [Related]
40. Glutamate-induced depression of EPSP-spike coupling in rat hippocampal CA1 neurons and modulation by adenosine receptors.
Ferguson AL; Stone TW
Eur J Neurosci; 2010 Apr; 31(7):1208-18. PubMed ID: 20345917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
